ENTITY
GlaxoSmithKline PLC

GlaxoSmithKline PLC (GSK LN)

127
Analysis
Health CareUnited Kingdom
GlaxoSmithKline PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.
more
01 Oct 2016 19:07

On Trade, An Era Is Ending

Whatever the outcome of the US election, President Barack Obama's departure in early 2017 will present renewed challenges for Asia Pacific trade....

Logo
327 Views
Share
12 Sep 2016 22:34

US Stock Market Seasonality:  Shemitah Redux, The Afterparty

Almost exactly a year ago I wrote a piece on stock market seasonality titled Stock Market Seasonality - Januaries, SuperBowls, Third Years,...

Logo
318 Views
Share
05 Sep 2016 08:03

ANIMAL SPIRITS REPORT 2: APAC Valuation and Earnings Snapshot

Asia Pacific Investment Strategy  In this series of introductory notes, Animal Spirits outlines the investment process and analytical framework we...

Share
09 Aug 2016 18:52

A 'heads Up' on Changing World Heights

A comprehensive world survey of population heights over the last century has thrown up some surprising results. Americans have had the smallest...

Logo
304 Views
Share
06 Jul 2016 16:44

Brexit; Unintended Consequences

In this brief piece we take a considered stance on the likelihood of Brexit actually proceeding in the wake of June’s referendum and examine some...

Share
x